RESMED INC. COMMON STOCK

ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health

30 Sep 2024 07:01:00 By Nasdaq GlobeNewswire

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

10 Sep 2024 15:05:00 By Nasdaq GlobeNewswire

Vaping Expected to Increase COPD Health and Economic Burden by 2050

10 Sep 2024 07:01:12 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

09 Sep 2024 08:45:18 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

03 Sep 2024 08:50:10 By NetDania Notify

ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

28 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

28 Aug 2024 09:44:29 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

27 Aug 2024 08:52:49 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

19 Aug 2024 08:47:38 By NetDania Notify

ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board

15 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: RESMED INC. COMMON STOCK

15 Aug 2024 12:21:55 By NetDania Notify

NetDania - New 12 months High: RESMED INC. COMMON STOCK

02 Aug 2024 11:19:22 By NetDania Notify

ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024

01 Aug 2024 15:05:01 By Nasdaq GlobeNewswire

ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024

03 Jul 2024 15:05:00 By Nasdaq GlobeNewswire

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

10 Jun 2024 08:05:00 By Nasdaq GlobeNewswire

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

23 May 2024 08:05:00 By Nasdaq GlobeNewswire

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

16 May 2024 15:35:00 By Nasdaq GlobeNewswire

ResMed Announces Participation in the RBCCM Global Healthcare Conference

07 May 2024 15:05:00 By Nasdaq GlobeNewswire

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

25 Apr 2024 15:05:01 By Nasdaq GlobeNewswire

ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024

04 Apr 2024 15:05:00 By Nasdaq GlobeNewswire